Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3616939
Max Phase: Preclinical
Molecular Formula: C48H86N14O9
Molecular Weight: 1003.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3616939
Max Phase: Preclinical
Molecular Formula: C48H86N14O9
Molecular Weight: 1003.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(C)CCC(=O)N[C@H](CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CC(C)C)C(N)=O
Standard InChI: InChI=1S/C48H86N14O9/c1-7-30(6)13-14-40(63)55-32(15-20-49)42(65)56-33(16-21-50)43(66)58-36(19-24-53)46(69)61-38(26-29(4)5)47(70)62-39(27-31-11-9-8-10-12-31)48(71)59-34(17-22-51)44(67)57-35(18-23-52)45(68)60-37(41(54)64)25-28(2)3/h8-12,28-30,32-39H,7,13-27,49-53H2,1-6H3,(H2,54,64)(H,55,63)(H,56,65)(H,57,67)(H,58,66)(H,59,71)(H,60,68)(H,61,69)(H,62,70)/t30?,32-,33+,34+,35+,36+,37+,38+,39-/m1/s1
Standard InChI Key: KOYZGURUKCVRLC-LSPXZINZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1003.30 | Molecular Weight (Monoisotopic): 1002.6702 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. De Zoysa GH, Cameron AJ, Hegde VV, Raghothama S, Sarojini V.. (2015) Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides., 58 (2): [PMID:25495219] [10.1021/jm501084q] |
2. De Zoysa GH, Glossop HD, Sarojini V.. (2018) Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans., 146 [PMID:29407961] [10.1016/j.ejmech.2018.01.023] |
Source(1):